View Document Preview and Link Document Date: 2003-10-24 18:00:40 Open Document File Size: 751,77 KB Share Result on Facebook
City San Francisco / Rockville / Shirley / Washington / DC / Chicago Kansas City / / Company Luitpold Pharmaceuticals Inc. / ACS / V-1 SONNENSCHEIN NATH & ROSENTHAL LLP / K Street N.W. LLP / American Regent Inc. / Snnenschein SONNENSCHEIN NATH & ROSENTHAL LLP / Scnnenschein SONNENSCHEIN NATH & ROSENTHAL LLP / SONNENSCHEIN NATH & ROSENTHAL LLP / ANDA Products Luitpold / ROSENTHAL LLP / / Country United States / / Currency TWD / USD / / / Event Product Recall / Product Issues / / Facility East Tower / / IndustryTerm injectable drug products / healthcare community / pharmaceutical industry / drug product / human drug products / healthcare product / biological product / diluent manufacturer / pharmaceutical manufacturers / healthcare / pharmaceutical / joint manufacturer / healthcare settings / healthcare professional / healthcare providers / drug products / / MedicalCondition fulminant hepatitis / interstitial nephritis / hepatitis / cancer / fever / acute renal failure / / MedicalTreatment medication errors / antibiotics / Medication Error / dialysis / / Organization Food and Drug Administration / office of Professional Discipline / U.S. Securities and Exchange Commission / Council for International Organizations of Medical Sciences / US Federal Reserve / / Person Peter S. Reichertz Filed / / / Position investigator / institutional pharmacist / physician / independent contractor / Contractor / sponsor/contractor / / Product Dockets Management Branch (HFA-3 05) / proposal / Sodium Chloride / Sterile Water for Injection / Reporting Medication / Dockets Management Branch (HFA-305) / H. Medication / / ProvinceOrState Maryland / New York / / Technology dialysis / / SocialTag 
Sxmenschein SONNENSCHEIN NATH